Glucose limitation activated AMPK and its subsequent SENP1-SIRT3 signaling, promoting OXPHOS and mitochondrial fusion, which was beneficial to the anti-tumor immunity of T cells (He et al., 2021). Here, SENP1 is linked to neoplasm.